Page last updated: 2024-10-24

negative regulation of phosphatidylinositol biosynthetic process

Definition

Target type: biologicalprocess

Any process that decreases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phosphatidylinositol. [GOC:dph, GOC:tb, GOC:vw]

Negative regulation of phosphatidylinositol biosynthetic process involves a complex interplay of cellular mechanisms aimed at controlling the production of phosphatidylinositol (PI), a crucial phospholipid that serves as a precursor for various signaling molecules and membrane components. This process is tightly regulated to maintain cellular homeostasis and ensure proper signaling and membrane integrity. Key aspects of this regulatory process include:

**1. Transcriptional Regulation:**
- Genes encoding enzymes involved in PI biosynthesis, such as phosphatidylinositol synthase (PIS), are subject to transcriptional control.
- Factors like transcription factors and signaling pathways can modulate the expression of these genes, either promoting or inhibiting PI production.

**2. Enzyme Inhibition:**
- Specific inhibitors target key enzymes in the PI biosynthetic pathway, such as PIS and phosphatidylinositol 4-kinase (PI4K).
- These inhibitors can act directly on the active site of the enzyme or indirectly by modulating regulatory mechanisms.

**3. Feedback Inhibition:**
- Products of the PI biosynthetic pathway, including PI itself and its downstream products, can exert feedback inhibition on the pathway.
- This mechanism helps to prevent excessive PI accumulation and maintain optimal levels.

**4. Post-translational Modifications:**
- Enzymes involved in PI biosynthesis can undergo post-translational modifications, such as phosphorylation or ubiquitination, which can alter their activity.
- These modifications are often triggered by signaling pathways and contribute to the dynamic regulation of PI production.

**5. Membrane Trafficking:**
- The localization and trafficking of enzymes involved in PI biosynthesis within cellular compartments are tightly controlled.
- This ensures that PI production occurs in specific cellular locations where it is needed.

**6. Protein-Protein Interactions:**
- Enzymes involved in PI biosynthesis can interact with other proteins, including regulatory proteins and scaffolding proteins.
- These interactions can modulate enzyme activity and influence the overall efficiency of the PI biosynthetic process.

**7. Microenvironment:**
- Factors such as pH, ion concentrations, and the presence of specific lipids in the cellular environment can influence the activity of enzymes involved in PI biosynthesis.

**8. Cellular Stress Responses:**
- Cells respond to stress conditions, such as oxidative stress, by altering the regulation of PI biosynthesis.
- This adaptive response helps to maintain cellular homeostasis and protect against damage.

**9. Signaling Pathways:**
- Various signaling pathways, including growth factor signaling, insulin signaling, and stress-activated pathways, influence the regulation of PI biosynthesis.
- These pathways often activate or inhibit specific enzymes and transcription factors involved in the process.

In summary, negative regulation of phosphatidylinositol biosynthetic process involves a complex network of molecular mechanisms that operate at multiple levels, from transcriptional regulation to post-translational modifications and cellular signaling pathways. These regulatory mechanisms ensure the precise control of PI production, thereby maintaining cellular homeostasis and supporting vital cellular processes, including signaling, membrane integrity, and cell growth.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Platelet-derived growth factor subunit AA platelet-derived growth factor subunit A that is encoded in the genome of human. [PRO:DNx, UniProtKB:P04085]Homo sapiens (human)

Compounds (1)

CompoundDefinitionClassesRoles
tak-632TAK-632 : A member of the class of benzothiazoles that is 1,3-benzothiazole substituted by (cyclopropanecarbonyl)amino, 4-fluoro-3-{2-[3-(trifluoromethyl)phenyl]acetamido}phenoxy, and cyano groups at positions 2, 6 and 7, respectively. It is a potent pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAF(V600E), BRAF(WT), respectively.(trifluoromethyl)benzenes;
aromatic ether;
benzothiazoles;
cyclopropylcarboxamide;
monofluorobenzenes;
nitrile;
secondary carboxamide
antineoplastic agent;
apoptosis inducer;
B-Raf inhibitor;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
necroptosis inhibitor